Alex R. Thurman - 07 Aug 2026 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
11 Aug 2026, 17:31:34 UTC
Prior SEC filing
21 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Diana Scherer, Attorney-in-Fact

Key filing fact

Alex R. Thurman filed Form 4 for GLAUKOS Corp (GKOS) on 11 Aug 2026.

Key facts

  • This page summarizes Alex R. Thurman's Form 4 filing for GLAUKOS Corp (GKOS).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 11 Aug 2026, 17:31.

Change

  • Previous filing in this sequence was filed on 21 Jul 2026.
  • Current net transaction value: -$3,602,600.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001920061 Primary reporting owner

Thurman Alex R.

Relationship
SVP & CHIEF FINANCIAL OFFICER
Address
C/O GLAUKOS CORPORATION, ONE GLAUKOS WAY, ALISO VIEJO
Signature
/s/ Diana Scherer, Attorney-in-Fact
Signature date
11 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GKOS transaction

Common Stock

Options Exercise

Transaction value
Shares
+20,000
Change %
+46%
Price
$33.81*
Shares after
63,906
Date
07 Aug 2026
Ownership
Direct
Footnotes
F1
GKOS transaction

Common Stock

Sale

Transaction value
$3,602,600
Shares
-20,000
Change %
-31%
Price
$180.13
Shares after
43,906
Date
07 Aug 2026
Ownership
Direct
Footnotes
F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GKOS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-20,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
07 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$33.81
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person and and 225 stock units purchased by the Reporting Person through the Issuer's Employee Stock Purchase Plan.

Footnote F2

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.

Footnote F3

This transaction was executed in multiple trades at prices ranging from $180.00 to $180.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Footnote F4

The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.

Footnote F5

These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .